APA (7th ed.) Citation

Chan, A. W., Pan, Y., Tong, J. H., Lung, R. W., Kwan, J. S., Chow, C., . . . To, K. (2020). Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development. The Journal of pathology, 251(1), 74-86. https://doi.org/10.1002/path.5418

Chicago Style (17th ed.) Citation

Chan, Anthony W‐H, et al. "Receptor Tyrosine Kinase Fusions Act as a Significant Alternative Driver of the Serrated Pathway in Colorectal Cancer Development." The Journal of Pathology 251, no. 1 (2020): 74-86. https://doi.org/10.1002/path.5418.

MLA (9th ed.) Citation

Chan, Anthony W‐H, et al. "Receptor Tyrosine Kinase Fusions Act as a Significant Alternative Driver of the Serrated Pathway in Colorectal Cancer Development." The Journal of Pathology, vol. 251, no. 1, 2020, pp. 74-86, https://doi.org/10.1002/path.5418.